FDAnews
www.fdanews.com/articles/203218-third-drug-substance-batch-from-emergent-plant-approved-for-release
johnson.gif

Third Drug Substance Batch From Emergent Plant Approved for Release

June 18, 2021

The FDA has approved a third batch of Johnson & Johnson (J&J) COVID-19 vaccine drug substance for release from the embattled Emergent Biosolutions plant in Bayview, Md. — but still hasn’t authorized the facility to resume production.

The agency said it wasn’t ready to include Emergent’s plant in J&J vaccine’s Emergency Use Authorization as a cleared manufacturing facility, but that it was continuing to “work through issues” with J&J and Emergent management.

The third batch joins two others cleared last week, allowing the drug substance to be used in vaccine production in either the U.S. or abroad.

View today's stories